Gradientech appoints Sumi Thaker as Chief Executive Officer to lead its next phase of commercial growth

Gradientech, a diagnostics company pioneering ultra-rapid antibiotic susceptibility testing, today announces the appointment of Sumi Thaker as Chief Executive Officer, with effective date 1 August 2026. Sumi will lead the company’s next phase of growth as Gradientech accelerates the global commercia...